Stay updated on Pembrolizumab & Romidepsin Combo Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.

Latest updates to the Pembrolizumab & Romidepsin Combo Clinical Trial page
- Check3 days agoChange DetectedThe visible Revision label on the page was updated from v3.6.0 to v3.6.2. This reflects a software revision rather than a change to the study content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study page now indicates that recruitment is closed by adding a recruitment note. It also introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), updates the Intervention/Treatment header styling, and updates the revision version to v3.6.0.SummaryDifference0.4%

- Check25 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a newer revision of the page.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous version tag; this reflects a minor update to the page's backend/content management without changes to the study details.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page’s display revision version was updated from v3.5.2 to v3.5.3, indicating a site release/maintenance update rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Romidepsin Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.